Image Analysis Group Teams With HeartcoR to Offer Single-Vendor Cardiac and Imaging CRO Solution

• Image Analysis Group (IAG), a global imaging CRO based in London, and HeartcoR Solutions, a specialized cardiac safety core lab based in Schaumburg, IL, have announced a strategic partnership to deliver fully integrated cardiac safety monitoring and imaging services to pharma and biotech sponsors worldwide.

• The collaboration combines HeartcoR’s ECG, cardiac monitoring, and endpoint adjudication capabilities with IAG’s multimodality imaging CRO expertise and proprietary DYNAMIKA™ technology platform, creating a unified operational and data environment across both service lines.

Image Analysis Group (IAG), a global imaging CRO headquartered in London, UK, and HeartcoR Solutions, LLC, a specialized cardiac safety core lab headquartered in Schaumburg, IL, announced a strategic partnership on May 6, 2026, to deliver fully integrated cardiac safety monitoring and imaging services to pharmaceutical and biotechnology sponsors worldwide. 

The partnership combines HeartcoR’s comprehensive core lab services — covering ECG, cardiac monitoring, and endpoint adjudication — with IAG’s multimodality imaging core lab expertise and DYNAMIKA™ technology platform, enabling an end-to-end workflow spanning cardiac safety reading, imaging acquisition, and quantitative image analysis within a unified operational and data environment. The arrangement is structured to operate as a single integrated service offering rather than a referral model, with both organizations maintaining their independent GxP-compliant quality systems throughout. 

For sponsors managing complex oncology, cardiology, neurology, and metabolic disorder trials, the partnership is designed to eliminate a common structural gap in clinical operations. Clinical teams have historically been required to source cardiac safety and imaging core lab services from separate vendors, creating fragmented data flows, delayed safety signal detection, and additional coordination burden. The integrated model offers a single point of accountability, defined data integration pathways between DYNAMIKA™ and HeartcoR’s cardiac safety management systems, and coordinated review of ECG and cardiac safety data alongside imaging biomarkers.

IAG’s DYNAMIKA™ platform delivers GxP-validated, FDA 21 CFR Part 11-compliant imaging data management and analysis for clinical trials across oncology, musculoskeletal, autoimmune, neurological, and cardiovascular therapeutic areas. HeartcoR brings deep expertise across 12-lead ECG, Holter monitoring, TTM event recording, and endpoint adjudication for Phase I through Phase IV clinical trials. Both organizations’ quality systems are aligned with FDA expectations and ICH Good Clinical Practice standards. 

“Biotech sponsors running complex oncology, cardiology, neurology, and metabolic disorder trials consistently tell us they want fewer vendors, faster data access, and higher confidence in their imaging and cardiac endpoints. By aligning HeartcoR’s cardiac safety expertise with IAG’s imaging services and DYNAMIKA™ platform, we are creating a true one-stop solution that streamlines operations and supports stronger safety and efficacy narratives for regulatory submissions.”

Dr. Olga Kubassova, Chief Executive Officer, Image Analysis Group (IAG)